Published in Drugs on March 01, 1985
Multiple cutaneous leiomyomas: pain relief with pulsed hysocine butyl bromide. Indian J Dermatol (2009) 1.03
Ensuring competency in end-of-life care: controlling symptoms. BMC Palliat Care (2002) 0.83
Effect of low doses of scopolamine on RR interval variability, baroreflex sensitivity, and exercise performance in patients with chronic heart failure. Heart (1996) 0.82
Anticholinergic syndrome following an unintentional overdose of scopolamine. Ther Clin Risk Manag (2009) 0.78
Prevention of peripheral side-effects of transdermal hyoscine by adjunctive therapy with low dosage of pyridostigmine. Br J Clin Pharmacol (1992) 0.75
Scopolamine for Management of Extrapyramidal Side Effects as a Result of Antipsychotic Medication Use: A Case Report and Brief Review of the Literature. Prim Care Companion CNS Disord (2016) 0.75
Transdermal hyoscine induced unilateral mydriasis. BMJ Case Rep (2012) 0.75
Ketoconazole: a review of its therapeutic efficacy in superficial and systemic fungal infections. Drugs (1982) 3.34
Enalapril. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in hypertension and congestive heart failure. Drugs (1986) 2.72
Pentoxifylline. A review of its pharmacodynamic and pharmacokinetic properties, and its therapeutic efficacy. Drugs (1987) 2.54
Fluconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in superficial and systemic mycoses. Drugs (1990) 2.52
Itraconazole. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in superficial and systemic mycoses. Drugs (1989) 2.41
Captopril: a preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 2.26
Prazosin: a review of its pharmacological properties and therapeutic efficacy in hypertension. Drugs (1977) 2.17
Metronidazole in anaerobic infections: a review of its activity, pharmacokinetics and therapeutic use. Drugs (1978) 2.12
Metoclopramide. An updated review of its pharmacological properties and clinical use. Drugs (1983) 2.02
Foscarnet. A review of its antiviral activity, pharmacokinetic properties and therapeutic use in immunocompromised patients with cytomegalovirus retinitis. Drugs (1991) 1.96
Ranitidine: a review of its pharmacology and therapeutic use in peptic ulcer disease and other allied diseases. Drugs (1982) 1.87
Ganciclovir. A review of its antiviral activity, pharmacokinetic properties and therapeutic efficacy in cytomegalovirus infections. Drugs (1990) 1.83
Disopyramide: a review of its pharmacological properties and therapeutic use in treating cardiac arrhythmias. Drugs (1978) 1.72
Cefotaxime. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1983) 1.71
Ipratropium bromide: a review of its pharmacological properties and therapeutic efficacy in asthma and chronic bronchitis. Drugs (1980) 1.67
Ceftriaxone. A review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1984) 1.65
Flunarizine. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.64
Amoxycillin/clavulanic acid: a review of its antibacterial activity, pharmacokinetics and therapeutic use. Drugs (1981) 1.64
Naproxen. A reappraisal of its pharmacology, and therapeutic use in rheumatic diseases and pain states. Drugs (1990) 1.61
Diclofenac sodium: a review of its pharmacological properties and therapeutic use in rheumatic diseases and pain of varying origin. Drugs (1980) 1.59
Triazolam: a review of its pharmacological properties and therapeutic efficacy in patients with insomnia. Drugs (1981) 1.55
Astemizole. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1984) 1.52
Nefopam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1980) 1.51
Cimetidine: a review of its pharmacological properties and therapeutic efficacy in peptic ulcer disease. Drugs (1978) 1.48
Amlodipine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in cardiovascular disease. Drugs (1991) 1.45
Labetalol: a review of its pharmacology and therapeutic use in hypertension. Drugs (1978) 1.44
Miconazole: a preliminary review of its therapeutic efficacy in systemic fungal infections. Drugs (1980) 1.43
Imipenem/cilastatin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic efficacy. Drugs (1987) 1.43
Loperamide: a review of its pharmacological properties and therapeutic efficacy in diarrhoea. Drugs (1978) 1.40
Fluoxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs (1986) 1.39
Mianserin: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1978) 1.37
Cefoperazone: A review of its in vitro antimicrobial activity, pharmacological properties and therapeutic efficacy. Drugs (1981) 1.33
Buprenorphine: a review of its pharmacological properties and therapeutic efficacy. Drugs (1979) 1.32
Terfenadine. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.29
Cefuroxime: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1979) 1.29
Sumatriptan. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the acute treatment of migraine and cluster headache. Drugs (1992) 1.28
Piperacillin. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1984) 1.26
Clozapine. A review of its pharmacological properties, and therapeutic use in schizophrenia. Drugs (1990) 1.23
Tamoxifen: a review of its pharmacological properties and therapeutic use in the treatment of breast cancer. Drugs (1978) 1.23
Clobazam: a review of its pharmacological properties and therapeutic use in anxiety. Drugs (1980) 1.22
Fenoterol: a review of its pharmacological properties and therapeutic efficacy in asthma. Drugs (1978) 1.22
Zimelidine: a review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1982) 1.22
Propofol. A review of its pharmacodynamic and pharmacokinetic properties and use as an intravenous anaesthetic. Drugs (1988) 1.19
Paroxetine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in depressive illness. Drugs (1991) 1.18
Vigabatrin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in epilepsy and disorders of motor control. Drugs (1991) 1.17
Ivermectin. A review of its antifilarial activity, pharmacokinetic properties and clinical efficacy in onchocerciasis. Drugs (1991) 1.17
Captopril: an update review of its pharmacological properties and therapeutic efficacy in congestive heart failure. Drugs (1983) 1.17
Econazole: a review of its antifungal activity and therapeutic efficacy. Drugs (1978) 1.14
Butorphanol: a review of its pharmacological properties and therapeutic efficacy. Drugs (1978) 1.13
Trazodone: a review of its pharmacological properties and therapeutic use in depression and anxiety. Drugs (1981) 1.13
Co-trimoxazole (trimethoprim-sulfamethoxazole): an updated review of its antibacterial activity and clinical efficacy. Drugs (1982) 1.12
Piroxicam: a review of its pharmacological properties and therapeutic efficacy. Drugs (1981) 1.11
Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Drugs (1984) 1.11
Ribavirin and inosiplex: a review of their present status in viral diseases. Drugs (1981) 1.11
Guanabenz. A review of its pharmacodynamic properties and therapeutic efficacy in hypertension. Drugs (1983) 1.11
Tinidazole in anaerobic infections: a review of its antibacterial activity, pharmacological properties and therapeutic efficacy. Drugs (1982) 1.10
Nalbuphine. A preliminary review of its pharmacological properties and therapeutic efficacy. Drugs (1983) 1.09
Nomifensine: A review of its pharmacological properties and therapeutic efficacy in depressive illness. Drugs (1979) 1.09
Omeprazole. An updated review of its pharmacology and therapeutic use in acid-related disorders. Drugs (1991) 1.09
Sucralfate. A review of its pharmacodynamic properties and therapeutic use in peptic ulcer disease. Drugs (1984) 1.08
Octreotide. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic potential in conditions associated with excessive peptide secretion. Drugs (1989) 1.08
Clarithromycin. A review of its antimicrobial activity, pharmacokinetic properties and therapeutic potential. Drugs (1992) 1.08
Bifonazole. A review of its antimicrobial activity and therapeutic use in superficial mycoses. Drugs (1989) 1.08
Amiodarone. An overview of its pharmacological properties, and review of its therapeutic use in cardiac arrhythmias. Drugs (1992) 1.08
Cinoxacin. A review of its pharmacological properties and therapeutic efficacy in the treatment of urinary tract infections. Drugs (1983) 1.07
Aztreonam. A review of its antibacterial activity, pharmacokinetic properties and therapeutic use. Drugs (1986) 1.06
Zopiclone. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy as an hypnotic. Drugs (1986) 1.05
Flecainide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1985) 1.05
Flurbiprofen: a review of its pharmacological properties and therapeutic use in rheumatic diseases. Drugs (1979) 1.04
Bumetanide. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use. Drugs (1984) 1.03
Topical minoxidil. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in alopecia areata and alopecia androgenetica. Drugs (1987) 1.01
Acyclovir. A review of its pharmacodynamic properties and therapeutic efficacy. Drugs (1983) 1.01
Famotidine. Pharmacodynamic and pharmacokinetic properties and a preliminary review of its therapeutic use in peptic ulcer disease and Zollinger-Ellison syndrome. Drugs (1986) 1.00
Betaxolol. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in hypertension. Drugs (1986) 1.00
Loxapine: a review of its pharmacological properties and therapeutic efficacy as an antipsychotic agent. Drugs (1978) 1.00
Paracetamol and phenacetin. Drugs (1986) 0.99
Lovastatin. A preliminary review of its pharmacodynamic properties and therapeutic use in hyperlipidaemia. Drugs (1988) 0.99
Ondansetron. Therapeutic use as an antiemetic. Drugs (1991) 0.98
Salbutamol in the 1980s. A reappraisal of its clinical efficacy. Drugs (1989) 0.98
Metoprolol: a review of its pharmacological properties and therapeutic efficacy in hypertension and angina pectoris. Drugs (1977) 0.97
Inosine pranobex. A preliminary review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy. Drugs (1986) 0.97
Ursodeoxycholic acid: a review of its pharmacological properties and therapeutic efficacy. Drugs (1984) 0.96
Budesonide. A preliminary review of its pharmacodynamic properties and therapeutic efficacy in asthma and rhinitis. Drugs (1984) 0.95
Trifluridine: a review of its antiviral activity and therapeutic use in the topical treatment of viral eye infections. Drugs (1982) 0.94
Carboplatin. A preliminary review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy in the treatment of cancer. Drugs (1989) 0.93
Fenofibrate. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic use in dyslipidaemia. Drugs (1990) 0.93
Probucol: a review of its pharmacological properties and therapeutic use in patients with hypercholesterolaemia. Drugs (1978) 0.92
Etretinate. A review of its pharmacological properties and therapeutic efficacy in psoriasis and other skin disorders. Drugs (1983) 0.92
Naproxen up to date: a review of its pharmacological properties and therapeutic efficacy and use in rheumatic diseases and pain states. Drugs (1979) 0.91
Tenoxicam. An update of its pharmacology and therapeutic efficacy in rheumatic diseases. Drugs (1991) 0.91
Temazepam: a review of its pharmacological properties and therapeutic efficacy as an hypnotic. Drugs (1981) 0.90
Guanfacine. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in the treatment of hypertension. Drugs (1986) 0.89
Cefoxitin: a review of its antibacterial activity, pharmacological properties and therapeutic use. Drugs (1979) 0.89